Sally Clive
Impact in
- Statistics and Probability top 5%
- Statistical Methods in Clinical Trials
-
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 18
- Cancer Treatment and Pharmacology 5
- Colorectal Cancer Treatments and Studies 5
- Cancer Diagnosis and Treatment 4
- Cancer Immunotherapy and Biomarkers 3
- PARP inhibition in cancer therapy 2
-
- Cancer Genomics and Diagnostics 2
- Co-authors
- Renaud Léonard (1 shared paper)Christopher J. Weir (2 shared papers)Thomas Jaki (2 shared papers)J. Michael Dixon (1 shared paper)Michelle D. Sakala (2 shared papers)Margaret M. Woo (2 shared papers)Mark Kagan (2 shared papers)Margaret Squier (1 shared paper)
- Journals
- Journal of Clinical Oncology (9 papers)Cancer Chemotherapy and Pharmacology (5 papers)British Journal of Cancer (4 papers)Annals of Oncology (2 papers)Cancer Medicine (1 paper)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
Sally Clive
28 papers receiving 516 citations
Peers
Comparison fields: 5 of 75
- Statistics and Probability 78
- Oncology 182
- Cancer Research 59
- Hematology 42
- Molecular Biology 168
Countries citing papers authored by Sally Clive
This map shows the geographic impact of Sally Clive's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally Clive with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally Clive more than expected).
Fields of papers citing papers by Sally Clive
This network shows the impact of papers produced by Sally Clive. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally Clive. The network helps show where Sally Clive may publish in the future.
Co-authors
The 25 scholars most cited alongside Sally Clive, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 65 | |
| 2 | 2012 | 52 | |
| 3 | 2013 | 48 | |
| 4 | 2017 | 45 | |
| 5 | 2014 | 45 | |
| 6 | 2013 | 44 | |
| 7 | 2010 | 44 | |
| 8 | 2002 | 30 | |
| 9 | 2010 | 25 | |
| 10 | 2011 | 17 | |
| 11 | Forearm blood flow and local responses to peptide vasodilators: a novel pharmacodynamic measure in the phase I trial of antagonist G, a neuropeptide growth factor antagonist. | 2001 | 17 |
| 12 | 2001 | 16 | |
| 13 | 2014 | 16 | |
| 14 | 2018 | 10 | |
| 15 | 2009 | 9 | |
| 16 | 2021 | 8 | |
| 17 | 2019 | 7 | |
| 18 | 2013 | 7 | |
| 19 | 2022 | 5 | |
| 20 | 2020 | 5 |
About Sally Clive
Sally Clive is a scholar working on Oncology, Cancer Research, Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 31 papers that have together received 538 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Colorectal Cancer Treatments and Studies (5 papers), Cancer Diagnosis and Treatment (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Statistical Methods in Clinical Trials (3 papers), Cancer Genomics and Diagnostics (2 papers), Advanced Breast Cancer Therapies (2 papers) and PARP inhibition in cancer therapy (2 papers). The work is most often cited by research in Statistics and Probability (78 citations), Oncology (182 citations), Cancer Research (59 citations), Hematology (42 citations) and Molecular Biology (168 citations). Sally Clive has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Renaud Léonard, Christopher J. Weir, Thomas Jaki, J. Michael Dixon, Michelle D. Sakala, Margaret M. Woo, Mark Kagan, Margaret Squier, Petr Kavan and D. Storey. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, British Journal of Cancer, Annals of Oncology and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.